The global SKF hydrobromide market is anticipated to grow at a significant CAGR during the forecast period. The major factor for the growth of the market is the increasing prevalence of neurological diseases such as Parkinson’s disease, restless leg syndrome, and many others which require dopamine antagonists for the treatment. These factors will fuel the growth of the global SKF hydrobromide market during the forecast period.
The dopamine antagonist agents like SKF hydrobromide are used as a first-line treatment for hyperprolactinemia, depression, and many others. Due to the COVID-19 pandemic, the cases of depression have increased due to which there will be high growth for the global SKF hydrobromide market during the forecast period. The dopamine antagonist attacks the dopamine receptor and mimics its effect during the treatment for Parkinson’s disease. Some of the key players in the global SKF hydrobromide market include Rand Systems, Anward, Cayman Chemical, Abacm, Alfa Chemistry, and many others.
Market Coverage
o By Type
o By End-User
o North America
o Europe
o Asia-Pacific
o Rest of the World
Key questions addressed by the report
o Recovery Timeline
o Deviation from pre-COVID forecast
o Most affected region and segment
Global SKF Hydrobromide Market by Segments
o High Purity (Above 99%)
o Low Purity (Below 97%)
o Purity (Above 97% and Below 99%)
o Medical Treatment
o Bioscience Research
o Others
Global SKF Hydrobromide Market by Region
North America
Europe
Asia-Pacific
Rest of the World